Skip to content

Effect of homeopathy on the pain, menstrual symptoms and quality of life in patients with primary dysmenorrhoea

Effect of homeopathy on the pain, menstrual symptoms and quality of life in students with primary dysmenorrhoea: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201207063706N14
Enrollment
60
Registered
2012-11-28
Start date
2012-11-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Primary dysmenorrhoea

Interventions

Intervention 1: Intervention: Homeopathic medicine, unique for each participant, twice with one month interval prescribed by a Homeopathic physician. Intervention 2: Control: Placebo (water), twice wi
Treatment - Drugs
Placebo
Intervention: Homeopathic medicine, unique for each participant, twice with one month interval prescribed by a Homeopathic physician.
Control: Placebo (water), twice with one month interval, after visit by a Homeopathic physician

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 27 Years

Inclusion criteria

Inclusion criteria: Eligibility criteria: age 18-27 years; single; having symptoms of primary dysmenorrhoea; pain severity of moderate to high (4.0-9.1); lack of pelvic and abdomen operations history; lack of allergy; non consumption of contraceptive drugs; non consumption of corticosteroids; non consumption of tobacco products; lack of allergy to Ibuprofen and the availability in visit specified days to visit.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of menstrual pain. Timepoint: During two months pre-intervention and two months after intervention. Method of measurement: Visual analogue scale (VAS).

Secondary

MeasureTime frame
Menstrual symptom severity. Timepoint: During two months pre-intervention and two months after intervention. Method of measurement: Symptom severity scale (SSS).;Quality of life. Timepoint: at baseline and 2 months after starting intervention. Method of measurement: SF-36.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhatereh Yousefi Rad

Faculty of Nursing & Midwifery- Tabriz University of Medical Sciences

mw.yousefi@yahoo.com+98 18 2422 2069

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026